THE ATG BASED MYELOABLATIVE CONDITIONING REGIMEN IS EFFECTIVE IN PATIENTS WITH RELAPSED OR HIGH-RISK T CELL LYMPHOMA

被引：0
|
作者：
Jun, Y. [1 ,2 ]
Chun, W. [1 ]
Shike, Y. [1 ]
Jieling, J. [1 ]
Liping, W. [1 ]
Yu, C. [1 ]
Jun, Y. [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematolog, Shanghai, Peoples R China
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1700
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [31] FOTEMUSTINE BASED PLATFORM AS CONDITIONING REGIMEN IN RELAPSED NON HODGKIN'S LYMPHOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
    Saltarelli, F.
    Ferrari, A.
    Bianchi, M.
    Piedimonte, M.
    Naso, V.
    Porrini, R.
    Veggia, B.
    Conte, E.
    Cox, M.
    Montefusco, E.
    HAEMATOLOGICA, 2013, 98 : 669 - 670
  • [32] Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma
    Bruno, Benedetto
    Sorasio, Roberto
    Patriarca, Francesca
    Montefusco, Vittorio
    Guidi, Stefano
    Busca, Alessandro
    Scime, Rosanna
    Console, Giuseppe
    Milone, Giuseppe
    Marotta, Giuseppe
    Dominietto, Alida
    Giaccone, Luisa
    Rotta, Marcello
    Falda, Michele
    Bacigalupo, Andrea
    Bosi, Alberto
    Corradini, Paolo
    Fanin, Renato
    Pollichieni, Simona
    Boccadoro, Mario
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (04) : 330 - 337
  • [33] Rituximab and Lenalidomide Plus Chidamide Can be an Effective Chemotherapy Regimen for Patients with Relapsed/ Refractory Angioimmunoblastic T-Cell Lymphoma
    Li, Cong
    Lei, Tao
    Yu, Haifeng
    Chen, Xi
    Han, Shuiyun
    Peng, Shuailing
    Yang, Haiyan
    BLOOD, 2022, 140 : 3689 - 3690
  • [34] HAPLOIDENTICAL TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING REGIMEN COULD SERVE AS AN OPTIONAL SALVAGE THERAPY FOR YOUNGER PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN LYMPHOMA
    Huang, H.
    Xiao, X.
    Jin, Z.
    Wu, D.
    HAEMATOLOGICA, 2017, 102 : 620 - 620
  • [35] Y-90-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma
    Gopal, Ajay K.
    Guthrie, Kathrine
    Rajendran, Joseph
    Pagel, John M.
    Oliviera, George
    Maloney, David G.
    Storb, Rainer F.
    Press, Oliver W.
    BLOOD, 2010, 116 (21) : 19 - 19
  • [36] Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
    Jiexian Ma
    Shunrong Sun
    Yingwei Hu
    Min Wu
    Lin Shen
    Wulipan Fulati
    Zilan Huang
    Wensi Qian
    Pingping Chen
    Mingyue Chen
    Yanhui Xie
    Bone Marrow Transplantation, 2022, 57 : 1612 - 1614
  • [37] Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
    Ma, Jiexian
    Sun, Shunrong
    Hu, Yingwei
    Wu, Min
    Shen, Lin
    Fulati, Wulipan
    Huang, Zilan
    Qian, Wensi
    Chen, Pingping
    Chen, Mingyue
    Xie, Yanhui
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1612 - 1614
  • [38] VALGANCICLOVIR PROPHYLAXIS IN HIGH RISK CMV PATIENTS UNDERGOING UMBILICAL CORD BLOOD TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING REGIMEN
    Angarano, R.
    Donnini, I.
    Nozzoli, C.
    Saccardi, R.
    Gozzini, A.
    Guidi, S.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S471 - S471
  • [39] Efficacy of ESHAP Regimen in Transplant Ineligible Patients With Relapsed/Refractory T-Cell Lymphoma
    Norasetthada, Lalita
    Tantiworawit, Adisak
    Rattanathammethee, Thanawat
    Chai-Adisaksopha, Chatree
    Chaipoh, Thanapat
    Rattarittamrong, Ekarat
    JOURNAL OF HEMATOLOGY, 2018, 7 (04) : 131 - 139
  • [40] Non-myeloablative allogeneic stem cell transplantation in patients with high-risk lymphoma:: a single-centre experience
    Console, G.
    Messina, G.
    Martino, M.
    Irrera, G.
    Pucci, G.
    Massara, E.
    Moscato, T.
    Fedele, R.
    Cuzzola, M.
    Gatto, F.
    Spiniello, E.
    Meliado, A.
    Rigolino, C.
    Dattola, A.
    Callea, I.
    Pontari, A.
    Monteleone, R.
    Stelitano, C.
    Callea, V.
    Mamone, D.
    Kropp, M.
    Molica, S.
    Abbadessa, A.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S247 - S247
12345